MRI predictors of amyloid pathology: results from the EMIF-AD multimodal biomarker discovery study

<strong>Background</strong> With the shift of research focus towards the pre-dementia stage of Alzheimer’s disease (AD), there is an urgent need for reliable, non-invasive biomarkers to predict amyloid pathology. The aim of this study was to assess whether easily obtainable measures from...

Full description

Bibliographic Details
Main Authors:	ten Kate, M, Redolfi, A, Peira, E, Bos, I, Vos, S, Vandenberghe, R, Gabel, S, Schaeverbeke, J, Scheltens, P, Blin, O, Richardson, J, Bordet, B, Wallin, A, Eckerstrom, C, Molinuevo, J, Engelborghs, S, Van Broeckhoven, C, Martinez-Lage, P, Popp, J, Tsolaki, M, Verhey, F, Baird, A, Legido-Quigley, C, Bertram, L, Dobricic, V, Zetterberg, H, Lovestone, S, Streffer, J, Bianchetti, S, Novak, G, Revillard, J, Gordon, M, Xie, Z, Wottschel, V, Frisoni, G, Visser, P, Barkhof, F
Format:	Journal article
Published:	BioMed Central 2018

MRI predictors of amyloid pathology: results from the EMIF-AD multimodal biomarker discovery study

Similar Items